Previously, Calhoun was a member of the boards and audit committees of Abraxis Bioscience, Myogen
, Aspreva Pharmaceuticals Company, Replidyne and Adams Respiratory Therapeutics.
Prior to his work on the Anschutz campus, Poticha served as a corporate attorney for Colorado-based pharmaceutical company, Myogen
, Inc., which was subsequently acquired by Gilead Sciences.
Acute injections of rhEPO (15,000 IU) did not change mRNA levels of VEGF, hypoxia-inducible factor 1[alpha] (HIF-1[alpha]), insulin-like growth factor, ferroportin, myogenic differentiation 1 (MyoD), and myogen
in biopsies obtained 2, 4, 6, and 10 h after injection of rhEPO, while small inductions of myoglobin, EPO-R, transferrin receptor, and myogenic regulatory factor (MRF4) were observed (39).
Clemmensen, Abbot, AstraZeneca, Bayer, Boehringer Ingelheim, Bristol Myers Squibb, Daiichi Sankyo, EliLilly, Evolva, Fibrex, Merck, Myogen
, Medtronic, Mitsubishi Pharma, The Medicines Company, Nycomed, Organon, Pfizer, Pharmacia, Sanofi, Searle, and Servier; J.
Lifetime Achievement Award - William Freytag, Ph.D., Former Chairman and CEO, Myogen
He was the principal founder of Myogen
, a biopharmaceutical company focused on the discovery, development and commercialisation of therapeutics for the treatment of cardiovascular and pulmonary disease.
He has been a consultant to Merck, GlaxoSmithKline, Bristol Myers Squibb, Novartis, CVRx, and Myogen
Most recently, Mr Turner served as CFO at Myogen
, a biopharmaceutical company, which he joined in 1999 and served until it was acquired by Gilead Sciences in 2006.
He has been a consultant to Merck, GlaxoSmithKline, Bristol-Myers Squibb, No-vartis, CVRx Inc, and Myogen
Select Pharma-Biotech And Biotech-Biotech Acquisitions Acquirer Acquired Premium Main Reason AstraZeneca Cambridge Antibody ~72% Technology Technology And Products Lilly Icos ~24% Product Gilead Myogen
~49% Product Sciences Merck Sirna ~95% Technology GenZyme AnorMed ~170% Product Stiefel Connectics -45% Product Genentech Tanox -47% Product Source: Reuters; Prudential Equity Group, LLC.
reports results for the integrated analysis of ARIES-1 and ARIES-2 pivotal trials of ambrisentan in pulmonary arterial hypertension; significant improvements observed for all primary and secondary endpoints.
Flolan is a specialty medication marketed by Myogen